Article info

Download PDFPDF
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis

Authors

  1. Correspondence to Professor Florence Sabatier, Cell Therapy Department, Hôpital de la Conception, Assistance Publique Hôpitaux de Marseille, Marseille 13005, France; florence.sabatier{at}ap-hm.fr
View Full Text

Citation

Magalon J, Velier M, Simoncini S, et al
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis

Publication history

  • Received July 31, 2018
  • Revised October 31, 2018
  • Accepted November 16, 2018
  • First published January 5, 2019.
Online issue publication 
February 14, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.